is fda banning compounded semaglutide & Tirzepatide 2025: Safe Use Guide Despite FDA ruling, compounded GLP-1s

Refills GLP-1 Side Effects and Safety GLP-1 treatments like semaglutide and tirzepatide are generally prescribed under medical supervision, but they can still cause side effects, especially during the early stages of use

Klinic verifies your benefits, assists with the prior authorization process, and works with insurance companies including Medicaid, Aetna, Blue Cross Blue Shield, and more, to ensure your treatment is covered

Real-world studies have confirmed these results: a 2025 study published in Diabetes, Obesity and Metabolism found tirzepatide was associated with greater weight loss over 6 months than semaglutide in patients without diabetes, consistent with the trial data

J.KariemM.ShuklaM.BallalS.KumarA.ChaharM.et al (2024)

It also has amino acids that help in production of glutathione for better muscle health

J Thromb Haemost 92:140150